David R. Margrave
Chief Financial Officer · Lantern Pharma Inc.
Individual
- 2025
- Dec 22, 2025
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David R. Margrave files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- D. Jeffrey Keyser - $100K in LTRN purchases and sales in the last 12 months
- Lee Troy Schalop - $100K in LTRN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David R. Margrave?
David R. Margrave is a corporate insider, tracked as Chief Financial Officer of Lantern Pharma Inc. (LTRN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David R. Margrave last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 2 filings going back to 2025.